{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T07:58:59Z","timestamp":1794383939744,"version":"4.9.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Azrieli Foundation and Zynerba"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The fragile X mental retardation (<jats:italic>FMR1<\/jats:italic>) gene contains an expansion-prone CGG repeat within its 5\u2032 UTR. Alleles with 55\u2013200 repeats are known as premutation (PM) alleles and confer risk for one or more of the <jats:italic>FMR1<\/jats:italic> premutation (PM) disorders that include Fragile X-associated Tremor\/Ataxia Syndrome (FXTAS), Fragile X-associated Primary Ovarian Insufficiency (FXPOI), and Fragile X-Associated Neuropsychiatric Disorders (FXAND). PM alleles expand on intergenerational transmission, with the children of PM mothers being at risk of inheriting alleles with\u2009&gt;\u2009200 CGG repeats (full mutation FM) alleles) and thus developing Fragile X Syndrome (FXS). PM alleles can be somatically unstable. This can lead to individuals being mosaic for multiple size alleles. Here, we describe a detailed evaluation of somatic mosaicism in a large cohort of female PM carriers and show that 94% display some evidence of somatic instability with the presence of a series of expanded alleles that differ from the next allele by a single repeat unit. Using two different metrics for instability that we have developed, we show that, as with intergenerational instability, there is a direct relationship between the extent of somatic expansion and the number of CGG repeats in the originally inherited allele and an inverse relationship with the number of AGG interruptions. Expansions are progressive as evidenced by a positive correlation with age and by examination of blood samples from the same individual taken at different time points. Our data also suggests the existence of other genetic or environmental factors that affect the extent of somatic expansion. Importantly, the analysis of candidate single nucleotide polymorphisms (SNPs) suggests that two DNA repair factors, <jats:italic>FAN1<\/jats:italic> and <jats:italic>MSH3<\/jats:italic>, may be modifiers of somatic expansion risk in the PM population as observed in other repeat expansion disorders.<\/jats:p>","DOI":"10.1038\/s41598-022-14183-0","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T09:07:38Z","timestamp":1655802458000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Both cis and trans-acting genetic factors drive somatic instability in female carriers of the FMR1 premutation"],"prefix":"10.1038","volume":"12","author":[{"given":"Ye Hyun","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce Eliot","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"Zafarullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blythe","family":"Durbin Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Holmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Usdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Tassone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,21]]},"reference":[{"key":"14183_CR1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.dnarep.2015.04.019","volume":"32","author":"X-N Zhao","year":"2015","unstructured":"Zhao, X.-N. & Usdin, K. The repeat expansion diseases: The dark side of DNA repair. DNA Repair 32, 96\u2013105 (2015).","journal-title":"DNA Repair"},{"key":"14183_CR2","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41593-020-0590-1","volume":"23","author":"CM Rodriguez","year":"2020","unstructured":"Rodriguez, C. M. et al. A native function for RAN translation and CGG repeats in regulating fragile X protein synthesis. Nat. Neurosci. 23, 386\u2013397 (2020).","journal-title":"Nat. Neurosci."},{"key":"14183_CR3","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.12688\/f1000research.11885.1","volume":"6","author":"A Rajaratnam","year":"2017","unstructured":"Rajaratnam, A. et al. Fragile X syndrome and fragile X-associated disorders. F1000Research 6, 2112 (2017).","journal-title":"F1000Research"},{"key":"14183_CR4","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3389\/fpsyt.2018.00564","volume":"9","author":"RJ Hagerman","year":"2018","unstructured":"Hagerman, R. J. et al. Fragile X-associated neuropsychiatric disorders (FXAND). Front. Psychiatry 9, 564 (2018).","journal-title":"Front. Psychiatry"},{"key":"14183_CR5","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1212\/01.wnl.0000281692.98200.f5","volume":"70","author":"MA Leehey","year":"2008","unstructured":"Leehey, M. A. et al. FMR1 CGG repeat length predicts motor dysfunction in premutation carriers. Neurology 70, 1397\u20131402 (2008).","journal-title":"Neurology"},{"key":"14183_CR6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/cge.12347","volume":"87","author":"DZ Loesch","year":"2015","unstructured":"Loesch, D. Z. et al. Psychological status in female carriers of premutation FMR1 allele showing a complex relationship with the size of CGG expansion. Clin. Genet. 87, 173\u2013178 (2015).","journal-title":"Clin. Genet."},{"key":"14183_CR7","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/nrneurol.2016.82","volume":"12","author":"RJ Hagerman","year":"2016","unstructured":"Hagerman, R. J. & Hagerman, P. Fragile X-associated tremor\/ataxia syndrome\u2014features, mechanisms and management. Nat. Rev. Neurol. 12, 403\u2013412 (2016).","journal-title":"Nat. Rev. Neurol."},{"key":"14183_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021728","volume":"6","author":"CM Yrigollen","year":"2011","unstructured":"Yrigollen, C. M., Tassone, F., Durbin-Johnson, B. & Tassone, F. The role of AGG interruptions in the transcription of FMR1 premutation alleles. PLoS\u00a0One 6, e21728 (2011).","journal-title":"PLoS\u00a0One"},{"key":"14183_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2017.65","volume":"3","author":"RJ Hagerman","year":"2017","unstructured":"Hagerman, R. J. et al. Fragile X syndrome. Nat. Rev. Dis. Primers. 3, 1\u201319 (2017).","journal-title":"Nat. Rev. Dis. Primers."},{"key":"14183_CR10","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/gm401","volume":"4","author":"F Tassone","year":"2012","unstructured":"Tassone, F. et al. FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States. Genome Med. 4, 100 (2012).","journal-title":"Genome Med."},{"key":"14183_CR11","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1001\/jama.291.4.460","volume":"291","author":"S Jacquemont","year":"2004","unstructured":"Jacquemont, S. Penetrance of the fragile X-Associated tremor\/ataxia syndrome in a premutation carrier population. JAMA 291, 460 (2004).","journal-title":"JAMA"},{"key":"14183_CR12","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1038\/s41436-021-01177-y","volume":"23","author":"EG Allen","year":"2021","unstructured":"Allen, E. G. et al. Refining the risk for fragile X-associated primary ovarian insufficiency (FXPOI) by FMR1 CGG repeat size. Genet. Med. 23, 1648\u20131655 (2021).","journal-title":"Genet. Med."},{"key":"14183_CR13","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1093\/humrep\/dem148","volume":"22","author":"EG Allen","year":"2007","unstructured":"Allen, E. G. et al. Examination of reproductive aging milestones among women who carry the FMR1 premutation. Hum. Reprod. 22, 2142\u20132152 (2007).","journal-title":"Hum. Reprod."},{"key":"14183_CR14","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/ajmg.a.35833","volume":"161A","author":"SL Nolin","year":"2013","unstructured":"Nolin, S. L. et al. Fragile X AGG analysis provides new risk predictions for 45\u201369 repeat alleles. Am. J. Med. Genet. A 161A, 771\u2013778 (2013).","journal-title":"Am. J. Med. Genet. A"},{"key":"14183_CR15","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3389\/fgene.2014.00318","volume":"5","author":"D Pretto","year":"2014","unstructured":"Pretto, D. et al. Clinical and molecular implications of mosaicism in FMR1 full mutations. Front. Genet. 5, 318 (2014).","journal-title":"Front. Genet."},{"key":"14183_CR16","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/(SICI)1096-8628(19960809)64:2<365::AID-AJMG26>3.0.CO;2-C","volume":"64","author":"IL Cohen","year":"1996","unstructured":"Cohen, I. L. et al. Mosaicism for the FMR1 gene influences adaptive skills development in fragile X-affected males. Am. J. Med. Genet. 64, 365\u2013369 (1996).","journal-title":"Am. J. Med. Genet."},{"key":"14183_CR17","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/(SICI)1096-8628(19960809)64:2<296::AID-AJMG13>3.0.CO;2-A","volume":"64","author":"CS Dobkin","year":"1996","unstructured":"Dobkin, C. S. et al. Tissue differences in fragile X mosaics: Mosaicism in blood cells may differ greatly from skin. Am. J. Med. Genet. 64, 296\u2013301 (1996).","journal-title":"Am. J. Med. Genet."},{"key":"14183_CR18","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/ajmg.a.31291","volume":"140A","author":"X-D Han","year":"2006","unstructured":"Han, X.-D., Powell, B. R., Phalin, J. L. & Chehab, F. F. Mosaicism for a full mutation, premutation, and deletion of the CGG repeats results in 22% FMRP and elevatedFMR1 mRNA levels in a high-functioning fragile X male. Am. J. Med. Genet. A 140A, 1463\u20131471 (2006).","journal-title":"Am. J. Med. Genet. A"},{"key":"14183_CR19","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1080\/14737159.2017.1377612","volume":"17","author":"P Jiraanont","year":"2017","unstructured":"Jiraanont, P. et al. Size and methylation mosaicism in males with Fragile X syndrome. Expert Rev. Mol. Diagn. 17, 1023\u20131032 (2017).","journal-title":"Expert Rev. Mol. Diagn."},{"key":"14183_CR20","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.3390\/ijms20163907","volume":"20","author":"M Field","year":"2019","unstructured":"Field, M. et al. Significantly elevated FMR1 mRNA and mosaicism for methylated premutation and full mutation alleles in two brothers with autism features referred for fragile X testing. Int. J. Mol. Sci. 20, 3907 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"14183_CR21","doi-asserted-by":"publisher","DOI":"10.1177\/1744629521995346","author":"W Saldarriaga","year":"1999","unstructured":"Saldarriaga, W., Gonz\u00e1lez-Teshima, L. Y., Forero-Forero, J. V., Tang, H.-T. & Tassone, F. Mosaicism in fragile X syndrome: A family case series. J. Intellect. Disabil. https:\/\/doi.org\/10.1177\/1744629521995346 (2021).","journal-title":"J. Intellect. Disabil."},{"key":"14183_CR22","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/(SICI)1096-8628(19990528)84:3<221::AID-AJMG11>3.0.CO;2-M","volume":"84","author":"B Schmucker","year":"1999","unstructured":"Schmucker, B. & Seidel, J. Mosaicism for a full mutation and a normal size allele in two fragile X males. Am. J. Med. Genet. 84, 221\u2013225 (1999).","journal-title":"Am. J. Med. Genet."},{"key":"14183_CR23","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3389\/fgene.2018.00173","volume":"9","author":"MR Mailick","year":"2018","unstructured":"Mailick, M. R. et al. Health profiles of mosaic versus non-mosaic FMR1 premutation carrier mothers of children with fragile X syndrome. Front. Genet. 9, 173 (2018).","journal-title":"Front. Genet."},{"key":"14183_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddv408","author":"X-N Zhao","year":"2015","unstructured":"Zhao, X.-N. et al. Muts\u03b2 generates both expansions and contractions in a mouse model of the Fragile X-associated disorders. Hum. Mol. Genet. https:\/\/doi.org\/10.1093\/hmg\/ddv408 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"14183_CR25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/humu.22177","volume":"34","author":"RA Lokanga","year":"2013","unstructured":"Lokanga, R. A. et al. Somatic expansion in mouse and human carriers of fragile X premutation alleles. Hum. Mutat. 34, 157\u2013166 (2013).","journal-title":"Hum. Mutat."},{"key":"14183_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1001242","volume":"6","author":"L M\u00f8llersen","year":"2010","unstructured":"M\u00f8llersen, L., Rowe, A. D., Larsen, E., Rognes, T. & Klungland, A. Continuous and periodic expansion of CAG repeats in Huntington\u2019s disease R6\/1 mice. PLoS Genet. 6, e1001242 (2010).","journal-title":"PLoS Genet."},{"key":"14183_CR27","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1093\/hmg\/ddaa139","volume":"29","author":"RM Pinto","year":"2020","unstructured":"Pinto, R. M. et al. Patterns of CAG repeat instability in the central nervous system and periphery in Huntington\u2019s disease and in spinocerebellar ataxia type 1. Hum. Mol. Genet. 29, 2551\u20132567 (2020).","journal-title":"Hum. Mol. Genet."},{"key":"14183_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/hmg\/4.1.1","volume":"4","author":"DG Monckton","year":"1995","unstructured":"Monckton, D. G., Wong, L. J., Ashizawa, T. & Caskey, C. T. Somatic mosaicism, germline expansions, germline reversions and intergenerational reductions in myotonic dystrophy males: Small pool PCR analyses. Hum. Mol. Genet. 4, 1\u20138 (1995).","journal-title":"Hum. Mol. Genet."},{"key":"14183_CR29","first-page":"114","volume":"56","author":"LJ Wong","year":"1995","unstructured":"Wong, L. J., Ashizawa, T., Monckton, D. G., Caskey, C. T. & Richards, C. S. Somatic heterogeneity of the CTG repeat in myotonic dystrophy is age and size dependent. Am. J. Hum. Genet. 56, 114\u2013122 (1995).","journal-title":"Am. J. Hum. Genet."},{"key":"14183_CR30","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.ebiom.2019.09.020","volume":"48","author":"M Ciosi","year":"2019","unstructured":"Ciosi, M. et al. A genetic association study of glutamine-encoding DNA sequence structures, somatic CAG expansion, and DNA repair gene variants, with Huntington disease clinical outcomes. EBioMedicine 48, 568\u2013580 (2019).","journal-title":"EBioMedicine"},{"key":"14183_CR31","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ajhg.2020.05.012","volume":"107","author":"K-H Kim","year":"2020","unstructured":"Kim, K.-H. et al. Genetic and functional analyses point to FAN1 as the source of multiple Huntington disease modifier effects. Am. J. Hum. Genet. 107, 96\u2013110 (2020).","journal-title":"Am. J. Hum. Genet."},{"key":"14183_CR32","unstructured":"Flower, M. Genetic Variation in DNA Repair Proteins Modifies the Course of Huntington\u2019s Disease. (2019)."},{"key":"14183_CR33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.dnarep.2016.01.001","volume":"40","author":"F Morales","year":"2016","unstructured":"Morales, F. et al. A polymorphism in the MSH3 mismatch repair gene is associated with the levels of somatic instability of the expanded CTG repeat in the blood DNA of myotonic dystrophy type 1 patients. DNA Repair 40, 57\u201366 (2016).","journal-title":"DNA Repair"},{"key":"14183_CR34","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1038\/s41431-018-0156-9","volume":"26","author":"SA Cumming","year":"2018","unstructured":"Cumming, S. A. et al. De novo repeat interruptions are associated with reduced somatic instability and mild or absent clinical features in myotonic dystrophy type 1. Eur. J. Hum. Genet. 26, 1635\u20131647 (2018).","journal-title":"Eur. J. Hum. Genet."},{"key":"14183_CR35","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1093\/hmg\/ddaa123","volume":"29","author":"F Morales","year":"2020","unstructured":"Morales, F. et al. Longitudinal increases in somatic mosaicism of the expanded CTG repeat in myotonic dystrophy type 1 are associated with variation in age-at-onset. Hum. Mol. Genet. 29, 2496\u20132507 (2020).","journal-title":"Hum. Mol. Genet."},{"key":"14183_CR36","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.dnarep.2007.01.002","volume":"6","author":"NJ Veitch","year":"2007","unstructured":"Veitch, N. J. et al. Inherited CAG.CTG allele length is a major modifier of somatic mutation length variability in Huntington disease. DNA Repair 6, 789\u2013796 (2007).","journal-title":"DNA Repair"},{"key":"14183_CR37","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/ana.24656","volume":"79","author":"C Bettencourt","year":"2016","unstructured":"Bettencourt, C. et al. DNA repair pathways underlie a common genetic mechanism modulating onset in polyglutamine diseases. Ann. Neurol. 79, 983\u2013990 (2016).","journal-title":"Ann. Neurol."},{"key":"14183_CR38","doi-asserted-by":"crossref","unstructured":"CAG repeat not polyglutamine length determines timing of Huntington\u2019s disease Onset. Cell 178, 887\u2013900.e14 (2019).","DOI":"10.1016\/j.cell.2019.06.036"},{"key":"14183_CR39","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/ajmg.b.30482","volume":"144B","author":"F Tassone","year":"2007","unstructured":"Tassone, F. et al. CGG repeat length correlates with age of onset of motor signs of the fragile X-associated tremor\/ataxia syndrome (FXTAS). Am. J. Med. Genet. B Neuropsychiatr. Genet. 144B, 566\u2013569 (2007).","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"14183_CR40","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1373\/clinchem.2009.136101","volume":"56","author":"S Filipovic-Sadic","year":"2010","unstructured":"Filipovic-Sadic, S. et al. A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome. Clin. Chem. 56, 399\u2013408 (2010).","journal-title":"Clin. Chem."},{"key":"14183_CR41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2353\/jmoldx.2008.070073","volume":"10","author":"F Tassone","year":"2008","unstructured":"Tassone, F., Pan, R., Amiri, K., Taylor, A. K. & Hagerman, P. J. A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations. J. Mol. Diagn. 10, 43\u201349 (2008).","journal-title":"J. Mol. Diagn."},{"issue":"3","key":"14183_CR42","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/(SICI)1096-8628(19990528)84:3<250::AID-AJMG17>3.0.CO;2-4","volume":"84","author":"F Tassone","year":"1999","unstructured":"Tassone, F. et al. FMRP expression as a potential prognostic indicator in fragile X syndrome. Am J Med Genet. 84, 250\u2013261 (1999).","journal-title":"Am J Med Genet."},{"key":"14183_CR43","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/978-1-4939-9080-1_4","volume":"1942","author":"BE Hayward","year":"2019","unstructured":"Hayward, B. E. & Usdin, K. Assays for determining repeat number, methylation status, and AGG interruptions in the fragile X-related disorders. Methods Mol. Biol. 1942, 49\u201359 (2019).","journal-title":"Methods Mol. Biol."},{"key":"14183_CR44","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1086\/302720","volume":"66","author":"F Tassone","year":"2000","unstructured":"Tassone, F. et al. Elevated levels of FMR1 mRNA in carrier males: A new mechanism of involvement in the fragile-X syndrome. Am. J. Hum. Genet. 66, 6\u201315 (2000).","journal-title":"Am. J. Hum. Genet."},{"key":"14183_CR45","doi-asserted-by":"crossref","unstructured":"James, G., Witten, D., Hastie, T. & Tibshirani, R. An Introduction to Statistical Learning: with Applications in R. (Springer Science & Business Media, 2013).","DOI":"10.1007\/978-1-4614-7138-7"},{"key":"14183_CR46","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/gim.2012.34","volume":"14","author":"CM Yrigollen","year":"2012","unstructured":"Yrigollen, C. M. et al. AGG interruptions within the maternal FMR1 gene reduce the risk of offspring with fragile X syndrome. Genet. Med. 14, 729\u2013736 (2012).","journal-title":"Genet. Med."},{"key":"14183_CR47","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/humu.22464","volume":"35","author":"RA Lokanga","year":"2014","unstructured":"Lokanga, R. A., Zhao, X.-N. & Usdin, K. The mismatch repair protein MSH2 is rate limiting for repeat expansion in a fragile X premutation mouse model. Hum. Mutat. 35, 129\u2013136 (2014).","journal-title":"Hum. Mutat."},{"key":"14183_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007719","volume":"14","author":"X Zhao","year":"2018","unstructured":"Zhao, X., Zhang, Y., Wilkins, K., Edelmann, W. & Usdin, K. MutL\u03b3 promotes repeat expansion in a Fragile X mouse model while EXO1 is protective. PLoS Genet. 14, e1007719 (2018).","journal-title":"PLoS Genet."},{"key":"14183_CR49","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/brainsci9030052","volume":"9","author":"X Zhao","year":"2019","unstructured":"Zhao, X. et al. Repeat instability in the Fragile X-related disorders: Lessons from a mouse model. Brain Sci. 9, 52 (2019).","journal-title":"Brain Sci."},{"key":"14183_CR50","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1002\/ajmg.a.61165","volume":"179","author":"SL Nolin","year":"2019","unstructured":"Nolin, S. L. et al. Expansions and contractions of the FMR1 CGG repeat in 5,508 transmissions of normal, intermediate, and premutation alleles. Am. J. Med. Genet. A 179, 1148\u20131156 (2019).","journal-title":"Am. J. Med. Genet. A"},{"key":"14183_CR51","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1866-1955-6-24","volume":"6","author":"CM Yrigollen","year":"2014","unstructured":"Yrigollen, C. M. et al. AGG interruptions and maternal age affect FMR1 CGG repeat allele stability during transmission. J. Neurodev. Disord. 6, 24 (2014).","journal-title":"J. Neurodev. Disord."},{"key":"14183_CR52","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3389\/fgene.2014.00244","volume":"5","author":"GJ Latham","year":"2014","unstructured":"Latham, G. J., Coppinger, J., Hadd, A. G. & Nolin, S. L. The role of AGG interruptions in fragile X repeat expansions: A twenty-year perspective. Front. Genet. 5, 244 (2014).","journal-title":"Front. Genet."},{"key":"14183_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.dnarep.2018.07.001","volume":"69","author":"KU Xiao-Nan Zhao","year":"2018","unstructured":"Xiao-Nan Zhao, K. U. FAN1 protects against repeat expansions in a Fragile X mouse model. DNA Repair 69, 1 (2018).","journal-title":"DNA Repair"},{"key":"14183_CR54","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3233\/JHD-200423","volume":"10","author":"X Zhao","year":"2021","unstructured":"Zhao, X. et al. Modifiers of somatic repeat instability in mouse models of Friedreich Ataxia and the Fragile X-related disorders: Implications for the Mechanism of somatic expansion in Huntington\u2019s disease. J. Huntington\u2019s Dis. 10, 149\u2013163 (2021).","journal-title":"J. Huntington\u2019s Dis."},{"key":"14183_CR55","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3390\/genes11111321","volume":"11","author":"A Ballester-Lopez","year":"2020","unstructured":"Ballester-Lopez, A. et al. Preliminary findings on CTG expansion determination in different tissues from patients with myotonic dystrophy type 1. Genes 11, 1321 (2020).","journal-title":"Genes"},{"key":"14183_CR56","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.64674","volume":"10","author":"R Kacher","year":"2021","unstructured":"Kacher, R. et al. Propensity for somatic expansion increases over the course of life in Huntington disease. Elife 10, e64674 (2021).","journal-title":"Elife"},{"key":"14183_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0216407","volume":"14","author":"E Corrales","year":"2019","unstructured":"Corrales, E. et al. Analysis of mutational dynamics at the DMPK (CTG)n locus identifies saliva as a suitable DNA sample source for genetic analysis in myotonic dystrophy type 1. PLoS\u00a0One 14, e0216407 (2019).","journal-title":"PLoS\u00a0One"},{"key":"14183_CR58","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1093\/hmg\/ddg352","volume":"12","author":"L Kennedy","year":"2003","unstructured":"Kennedy, L. et al. Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis. Hum. Mol. Genet. 12, 3359\u20133367 (2003).","journal-title":"Hum. Mol. Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14183-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14183-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14183-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T05:59:46Z","timestamp":1669355986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14183-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,21]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["14183"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-14183-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,21]]},"assertion":[{"value":"23 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Flora Tassone received funds from Azrieli Foundation and Zynerba for studies in Fragile X syndrome. The other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10419"}}